Phenotypic modifications of human mesangial cells by extracellular matrix: The importance of matrix in the contractile response to reactive oxygen species

Experimental Nephrology

Volumn 8, Issue 2, 2000, Pages 97-103

  Iglesias De La Cruz, M Carmen ^a   Ruiz Torres, M Piedad ^a   De Lucio Cazaña, F Javier ^a   Rodríguez Puyol, Manuel ^a   Rodríguez Puyol, Diego ^a,b  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Collagen I; Collagen IV; Contraction; Extracellular matrix; Hydrogen peroxide; Mesangial cells; Proliferation; Reactive oxygen species

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MESANGIUM CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0034022896     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020655     Document Type: Article

References (36)

1. Schor N, Ichikawa I, Brenner BM: Mechanisms of action of various hormones and vasoactive substances on glornerular ultrafiltration in the rat. Kidney Int 1981;20:442-451.
2. Dworkin LD, Ichikawa I, Brenner MB: Hormonal regulation of glomerular function. Am J Physiol 1983;244:F95-F104.
3. Kon V, Ichikawa I: Hormonal regulation of glomerular filtration. Annu Rev Med 1985;36: 515-531.
4. Latta H, Fliegel S: Mesangial fenestrations, sieving filtration and flow. Lab Invest 1985;52: 591-598.
5. Mené P, Simonson MS, Dunn MJ: Physiology of the mesangial cell. Physiol Res 1989;69: 1347-1424.
6. Rupprecht HD, Schocklmann HO, Sterzel RB: Cell-matrix interactions in the glomerular mesangium. Kidney Int 1996;49:1575-1582.
7. 1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro embryogenesis. J Cell Physiol 1990; 142:117-128.
8. Marx M, Perlmutter RA, Madri JA: Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro embryogenesis. J Clin Invest 1994;93:131-139.
9. Nishikawa Y, Tokusashi Y, Kadohama T, Nishimori H, Ogawa K: Hepatocytic cells form bile duct-like structures within a three-dimensional collagen gel matrix. Exp Cell Res 1996; 15:223:357-371.
10. Sakatsume M, Saito A, Takeda T, Yamazaki H, Narita I, Nishi S, Nakagawa Y, Arakawa M: Mesangial cell-matrix interactions: Modulation of matrix expression in mesangial cells by extracellular matrices. Exp Nephrol 1995;3: 362-368.
11. Saito K, Shimizu F, Sato T, Oite T: Modulation of human mesangial cell behaviour by extracellular matrix components - the possible role of interstitial type III collagen. Clin Exp Immunol 1993;91:510-515.
12. Kitamura M, Mitarai T, Maruyama N, Nagasawa R, Yoshida H, Sakai O: Mesangial cell behaviour in a three-dimensional extracellular matrix. Kidney Int 1991;40:653-661.
13. Cosio FG: Fibronectin metabolism by human mesangial cells: Effects of collagens. Am J Physiol 1993;264:F106-F116.
14. García-Escribano C, Díez-Marqués ML, González-Rubio M, Rodríguez-Puyol M, Rodriguez-Puyol D: Somatostatin antagonizes angiotensin II effects on mesangial cell contraction and glomerular filtration. Kidney Int 1993;43: 324-333.
15. López-Farre A, Gómez-Garre D, Bernabeu F, Montanes I, Millas I, López-Novoa JM: Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. Kidney Int 1991;39:624-630.
16. Elger M, Drenckhahn D, Nobiling R, Mundel P, Kriz W: Cultured rat mesangial cells contain smooth muscle alpha-actin not found in vivo. Am J Pathol 1993;142:497-509.
17. Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Shikata K, Nagai R, Ota Z: Phenotypic changes of the mesangium in diabetic nephropathy. J Diabetes Complications 1995;9:282-284.
18. Arai M, Wada A, Isaka Y, Akagi Y, Sugiura T, Miyazaki M, Moriyama T, Kaneda Y, Naruse K, Naruse M: In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. Biochem Biophys Res Commun 1995;206:525-532.
19. Kitamura M, Maruyama N, Mitarai T, Nagasawa R, Yoshida H, Sakai O: Extracellular matrix contraction by cultured mesangial cells: Modulation by transforming growth factor-beta and matrix components. Exp Mol Pathol 1992;56: 132-143.
20. Duque I, García-Escribano C, Rodríguez-Puyol M, Díez-Marqués ML, López-Novoa JM, Arribas I, Hernando L, Rodríguez-Puyol D: Effects of reactive oxygen species on cultured rat mesangial cells and isolated rat glomeruli. Am J Physiol 1992;263:F466-F473.
21. Duque I, Rodríguez-Puyol M, Ruiz P, González-Rubio M, Díez-Marqués ML, Rodríguez-Puyol D: Calcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells. J Pharmacol Exp Ther 1993;267:612-616.
22. Díez ML, García-Escribano C, Medina K, Boyano MC, Arilla E, Torrecilla G, Rodríguez D, Rodríguez M: Effects of somatostatin on cultured human mesangial cells. Endocrinology 1995;136:3444-3451.
23. Form DM, Pratt BM, Madri JA: Endothelial cell proliferation during angiogenesis: In vitro modulation by basement membrane components. Lab Invest 1986;55:521-530.
24. Rodríguez-Puyol D, Lamas S, Olivera A, López-Farre A, Ortega G, Hernando L, López-Novoa JM: Actions of cyclosporin A on cultured rat mesangial cells. Kidney Int 1992;35: 632-637.
25. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
26. 2 and prostacyclin. Kidney Int 1990;38:232-239.
27. Aebi HE; Catalase; in Bergmeyer HU (ed): Methods of Enzymatic Analysis. Weinheim, Verlag Chemie, 1983, vol III, pp 273-285.
28. Ruiz-Torres P, Lucio FJ, González-Rubio M, Rodríguez-Puyol M, Rodríguez-Puyol D: A dual effect of somatostatin on the proliferation of cultured rat mesangial cells. Biochem Biophys Res Commun 1993;195:1057-1062.
29. Miralem T, Whiteside CI, Templeton DM: Collagen type I enhances endothelin-mediated contraction and induces nonproliferating phenotype in mesangial cells. Am J Physiol 1996; 270:F960-F970.
30. Ardaillou N, Hagege J, Nivez MP, Ardaillou R, Schlöndorff D: Vasoconstrictor-evoked prostaglandin synthesis on cultured human mesangial cells. Am J Physiol 1985;248:F240-F246.
31. 2 synthesis in rat glomerular mesangial cells. Am J Physiol 1989;256:F171-F178.
32. 2 and prostacyclin. Kidney Int 1990;38:232-239.
33. Mené P, Dunn MJ: Modulation of mesangial cell contraction by arachidonate metabolites. Trans Assoc Am Physicians 1986;99:125-131.
34. Vleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA: Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol 1995;44:211-219.
35. Floege J, Alpers CE, Burns MW, Pritzl P, Gordon K, Couser WG, Johnson RJ: Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992;66: 485-497.
36. Johnson KJ, Weinberg JM: Postischemic renal injury due to oxygen radicals. Curr Opin Nephrol Hypertens 1993;2:625-635.